Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 2
2009 1
2010 1
2012 2
2013 3
2014 5
2015 3
2016 4
2017 3
2018 4
2019 1
2020 4
2021 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.
Campana LG, Farronato S, Hodgetts J, Odili J, Vecchiato A, Bracken A, Baier S, Bechara FG, Borgognoni L, Caracò C, Carvalhal S, Covarelli P, Clover J, Eisendle K, Fantini F, Fierro MT, Farricha V, Gregorelli C, Hafner J, Kunte C, Gerlini G, Hessam S, Mandalà M, Piazzalunga D, Quaglino P, Snoj M, Ross AM, Trigona B, Moreno-Ramirez D, Tauceri F, Peach H, Rutkowski P, Muir T, de Terlizzi F, Patuzzo R, Mühlstädt M, Dietrich KA, Mussack T, Matteucci P, Kis E, Ascierto P, Sersa G, Valpione S; Melanoma Delphi Working Group. Campana LG, et al. Br J Surg. 2023 Jun 12;110(7):818-830. doi: 10.1093/bjs/znad105. Br J Surg. 2023. PMID: 37131298
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M, Amaro A, Solari N, Gangemi R, Croce E, Tanda ET, Spagnolo F, Filaci G, Pfeffer U, Croce M. Marseglia M, et al. Among authors: solari n. Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043. Cancers (Basel). 2021. PMID: 33922591 Free PMC article. Review.
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F, Croce E, Boutros A, Tanda E, Cecchi F, Mascherini M, Solari N, Cafiero F, Queirolo P. Spagnolo F, et al. Among authors: solari n. Expert Rev Anticancer Ther. 2020 May;20(5):403-413. doi: 10.1080/14737140.2020.1760847. Epub 2020 May 3. Expert Rev Anticancer Ther. 2020. PMID: 32326767 Review.
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I, Pastorino L, Tanda ET, Andreotti V, Dalmasso B, Solari N, Mascherini M, Cabiddu F, Guadagno A, Coco S, Allavena E, Bruno W, Pietra G, Croce M, Gangemi R, Piana M, Zoppoli G, Ferrando L, Spagnolo F, Queirolo P, Ghiorzo P. Vanni I, et al. Among authors: solari n. Int J Mol Sci. 2023 Feb 21;24(5):4302. doi: 10.3390/ijms24054302. Int J Mol Sci. 2023. PMID: 36901733 Free PMC article.
A multicenter retrospective study on 4480 implanted PICC-ports: A GAVeCeLT project.
Bertoglio S, Annetta MG, Brescia F, Emoli A, Fabiani F, Fino M, Merlicco D, Musaro A, Orlandi M, Parisella L, Pinelli F, Reina S, Selmi V, Solari N, Tricarico F, Pittiruti M. Bertoglio S, et al. Among authors: solari n. J Vasc Access. 2022 Jan 17:11297298211067683. doi: 10.1177/11297298211067683. Online ahead of print. J Vasc Access. 2022. PMID: 35034480
40 results